Companies: 10,795·Total market cap: $144.5T

Advanced Biomed Inc. Common Stock

Advanced Biomed Inc. Common Stock

ADVBNASDAQHealthcare● Active

$3.94

$-0.23(-5.52%)

Market Cap$4263557

P/E Ratio—

52W High$19.72

52W Low$3.61

Avg Volume456K

Open$4.17

Beta0.69

Net Income Financials Revenue

Advanced Biomed Inc. Common Stock (ADVB) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ADVB · net income · updated Jun 9, 2026

Core profitability metrics

ADVB · net income · margin · TTM · CAGR

Net income was −$101,524 for FY2025 (fiscal year ending 2025-06-30), up 96.4% year-over-year. Net profit margin was —.

FY2025 Net Income−$101,524▲ +96.4% YoY

Trailing 12M (TTM)−$677,611trailing 4 quarters sum

Net Profit Margin——

YoY Change+96.4%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · ADVB net income history · ADVB profit margin

Annual net income data

ADVB · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$101,524▲ +96.4%—$0

FY2024Loss−$2.8M▼ 2189.5%—$0

FY2023Loss−$121,521▲ +97.0%—$0

FY2022Loss−$4.0M▼ 119.2%—$0

FY2021Loss−$1.8M——$0

Net income vs peers (Healthcare)

ADVB vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Advanced Biomed Inc. Common StockYOU

ADVB

−$101,524+96.4%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Advanced Biomed Inc. Common Stock (ADVB) reported net income of −$101,524 for FY2025 (fiscal year ending 2025-06-30), up 96.4% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Advanced Biomed Inc. Common Stock has not yet achieved annual profitability based on available data (5 fiscal years). The company has reported net losses across all available periods.

Advanced Biomed Inc. Common Stock's net profit margin was — for FY2025, based on the latest annual results.

Investors sometimes search for "Advanced Biomed Inc. Common Stock net worth" — the company's market capitalization is a separate figure from ADVB net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ADVB net income · 4 questions

Advanced Biomed Inc. Common Stock is not currently profitable on an annual basis. The company reported a net loss of $101,524 for FY2025.

is ADVB profitabledoes ADVB make a profitADVB profitabilityADVB profitable company

▸ Source: FMP /income-statement · GAAP · Advanced Biomed Inc. Common Stock · Advanced Biomed Inc. Common Stock SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026